Renhua Li

Title: Renhua Li: Innovator in Factor Xa Inhibition

Introduction

Renhua Li is a prominent inventor based in Noblesville, Indiana, known for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, he has made remarkable strides in developing innovative compounds that serve as inhibitors for critical biological processes.

Latest Patents

Among his latest patents, Renhua Li has developed pyrazolobenzamides and derivatives as factor Xa inhibitors. This application describes compounds of Formula I: P-P-M-MI or pharmaceutically acceptable salt forms thereof. These compounds are particularly useful as inhibitors of trypsin-like serine proteases, specifically factor Xa. Another notable patent involves guanidine mimics as factor Xa inhibitors. This application details nitrogen-containing heteroaromatics and their derivatives, wherein rings D-E represent guanidine mimics, which are effective as inhibitors of factor Xa.

Career Highlights

Renhua Li has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Pharma Company and Bristol-Myers Squibb Company. His work in these organizations has allowed him to contribute to the development of groundbreaking medical treatments.

Collaborations

Throughout his career, Renhua Li has collaborated with esteemed colleagues such as Mimi Lifen Quan and Patrick Y Lam. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Renhua Li's work in developing factor Xa inhibitors showcases his dedication to advancing pharmaceutical science. His innovative patents and collaborations highlight his significant impact on the industry.